🔎 Trials Near Me

Hjem › KOLS › Florida › Miami

Kliniske studier for KOLS i Miami, FL

18 studier for KOLS søker deltakere på steder i og rundt Miami (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

RekruttererFase 3
  • Research Site, Miami
  • Research Site, Miami
Alder 40 til 80 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

RekruttererFase 3
  • Elite Clinical Research - Miami- Site Number : 8400167, Miami
  • DL Research Solutions- Site Number : 8400140, Miami
  • Phoenix Medical Research - Miami - 24th Street- Site Number : 8400027, Miami
  • og 3 flere
Alder 40 til 80 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07190222

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

RekruttererFase 2
  • Suncoast Research Group, LLC Miami - Little Havana dba Flourish Research, Miami
Alder 40 til 85 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07684820

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

RekruttererFase 3
  • GSK Investigational Site, Miami
Alder 40 til 80 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07780656

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

RekruttererFase 2
  • Millennium Medical Research - Miami, Miami
Alder 40 til 75 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07759245

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

RekruttererFase 3
  • University of Miami Dermatology Clinical Trials Unit- Site Number : 8400078, Miami
  • MCR Research- Site Number : 8400004, Miami
  • Nuren Medical & Research Center- Site Number : 8400030, Miami
  • og 1 flere
Alder 40 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07190209

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

RekruttererFase 4
  • University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
  • Finlay Medical Research- Site Number : 8400010, Miami
Alder 40 til 85 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07053423

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

RekruttererFase 2
  • Research Site, Miami
  • Research Site, Miami
  • Research Site, Miami
  • og 2 flere
Alder 40 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07082738

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

RekruttererFase 3
  • Research Site, Miami
Alder 40 til 80 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

RekruttererFase 3
  • Research Site, Miami
  • Research Site, Miami
  • Research Site, Miami
Alder 40 til 80 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

RekruttererFase 2/3
  • Reed Medical Research, Miami
Alder 35 til 80 · Alle kjønn · Oppdatert 31. aug. 2026 · NCT07363694

Rademikibart IV for Acute Asthma and COPD Exacerbation

RekruttererFase 2
  • Columbus Clinical Services, LLC, Miami
  • Pharmax Research of South Florida, Inc., Miami
Alder 18 til 85 · Alle kjønn · Oppdatert 27. aug. 2026 · NCT07705737

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

RekruttererFase 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
Alder 40 til 75 · Alle kjønn · Oppdatert 28. jul. 2026 · NCT07177339

Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD

Rekrutterer
  • University of Miami, Miami
Alder 18 til 100 · Alle kjønn · Oppdatert 22. jun. 2026 · NCT06578156

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

RekruttererFase 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • og 4 flere
Alder 40 til 80 · Alle kjønn · Oppdatert 9. apr. 2026 · NCT06961214

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

RekruttererFase 3
  • GSK Investigational Site, Miami
Alder 40 til 80 · Alle kjønn · Oppdatert 8. okt. 2025 · NCT06959095

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Rekrutterer
  • Reliable Research, Inc., Miami
  • NewGen Health Group, Miami
Alder 30 og eldre · Alle kjønn · Oppdatert 6. feb. 2025 · NCT05204888

KOLS-studier i andre byer

Andre studier i Miami

Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.